Summary
BioSight, a privately-held pharmaceutical company developing innovative therapeutics for hematological malignancies and disorders.
Deals Overview
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
Senior Management
Ruth Ben Yakar
CEO
Roy Golan
CFO
Pini Orbach
Chairman